RxDoctor Payments Data

Morgan Edstrom

Physician Assistant · Greensboro, NCNPI 1497468524

Payments from drug & device makers

$935in general payments, 2019–2025

Across 38 payments — averaging $24.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$219
  • Novo Nordisk$185
  • AbbVie$111
  • Otsuka America Pharmaceutical, Inc.$82
  • Lundbeck LLC$63
  • Lilly USA, LLC$61
  • plus $215 from 8 others

What the payments were for

  • Food & beverage$935100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$935 in reported general payments places this provider in the 65th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$22,083
Medicare patients
67
Services billed
339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$62,480
MounjaroTirzepatide31$41,786
JardianceEmpagliflozin32$30,222
FarxigaDapagliflozin Propanediol25$27,998
EliquisApixaban18$16,971
Nurtec OdtRimegepant Sulfate17$16,885
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,830
Levothyroxine Sodium153$1,984
SynthroidLevothyroxine Sodium20$1,956
Gabapentin92$1,911
Rosuvastatin Calcium149$1,817
Omeprazole95$1,540
Atorvastatin Calcium155$1,521
Albuterol Sulfate HfaAlbuterol Sulfate46$1,328
Duloxetine Hcl39$1,210

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$185$62,48066 claims
Lilly USA, LLCMounjaro$61$41,78631 claims
PfizerEliquis, Nurtec Odt$20$33,85635 claims
Boehringer IngelheimJardiance$19$30,22232 claims
AstraZenecaFarxiga$219$27,99825 claims
GSKTrelegy Ellipta$41$11,83017 claims
AbbVieSynthroid$111$1,95620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →